Josefin V. Eklof

Copenhagen, 2900, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care.

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care.

Journal: Biomedicines

Published: April 20, 2026

Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD.

Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD.

Journal: Journal of clinical medicine

Published: March 23, 2026

Short-term oral corticosteroid use and risk for major adverse cardiovascular events within one year in patients with chronic obstructive pulmonary disease, a Danish registry-based cohort study.

Short-term oral corticosteroid use and risk for major adverse cardiovascular events within one year in patients with chronic obstructive pulmonary disease, a Danish registry-based cohort study.

Journal: European clinical respiratory journal

Published: February 23, 2026

Chronic obstructive pulmonary disease and rheumatoid arthritis: severe exacerbations, pneumonia, and death in a population-based cohort.

Chronic obstructive pulmonary disease and rheumatoid arthritis: severe exacerbations, pneumonia, and death in a population-based cohort.

Journal: Scandinavian journal of rheumatology

Published: February 16, 2026

Inhaled Corticosteroid Use and Risk of Haemophilus influenzae Isolation in Patients with Bronchiectasis: A Retrospective Cohort Study.

Inhaled Corticosteroid Use and Risk of Haemophilus influenzae Isolation in Patients with Bronchiectasis: A Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: October 17, 2025

COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbation.

COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbation.

Journal: BMJ open respiratory research

Published: September 19, 2025

Evening administration of long-acting muscarinic antagonists in COPD - a randomized controlled trial.

Evening administration of long-acting muscarinic antagonists in COPD - a randomized controlled trial.

Journal: BMC pulmonary medicine

Published: June 09, 2025

Inhaled Corticosteroids and Risk of Staphylococcus aureus Isolation in Bronchiectasis: A Register-Based Cohort Study.

Inhaled Corticosteroids and Risk of Staphylococcus aureus Isolation in Bronchiectasis: A Register-Based Cohort Study.

Journal: Journal of clinical medicine

Published: May 29, 2025

Risk of Major Adverse Cardiovascular Events During Acute Streptococcus pneumoniae Infection in COPD Patients.

Risk of Major Adverse Cardiovascular Events During Acute Streptococcus pneumoniae Infection in COPD Patients.

Journal: JACC. Advances

Published: March 08, 2025

Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary Disease.

Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary Disease.

Journal: Biomedicines

Published: February 05, 2025

Pulmonary pressure increases during acute exacerbation in COPD and clinical outcome.

Pulmonary pressure increases during acute exacerbation in COPD and clinical outcome.

Journal: The European respiratory journal

Published: January 28, 2025

The impact of social distancing on mental health during the COVID-19 pandemic: a nationwide study of 4.6 million Danish adults.

The impact of social distancing on mental health during the COVID-19 pandemic: a nationwide study of 4.6 million Danish adults.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: January 28, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026